Security Snapshot

BIOMERICA INC - Common Stock (BMRA) Institutional Ownership

CUSIP: 09061H307

13F Institutional Holders and Ownership History from Q3 2016 to Q2 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.57

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
BMRA on Nasdaq
Price per share
$0.57
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • BMRA - BIOMERICA INC - Common Stock is tracked under CUSIP 09061H307.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 21 to 0 between Q1 2025 and Q2 2025.
  • Reported value moved from $536,314 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 09061H307?
CUSIP 09061H307 identifies BMRA - BIOMERICA INC - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of BIOMERICA INC - Common Stock (BMRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$536,314 $0.57 0
2025 Q1 946,580 $536,314 -$244,329 $0.57 21
2024 Q4 1,406,428 $420,797 -$75,064 $0.30 21
2024 Q3 1,624,300 $532,684 -$224,344 $0.33 25
2024 Q2 2,217,085 $974,047 -$1,074,483 $0.44 31
2024 Q1 3,728,807 $3,102,233 +$75,977 $0.83 34
2023 Q4 3,746,692 $4,683,152 -$181,479 $1.25 32
2023 Q3 3,993,049 $3,431,018 -$422,267 $0.86 34
2023 Q2 4,411,951 $6,000,502 -$457,511 $1.36 35
2023 Q1 4,719,769 $8,825,486 +$2,260,910 $1.87 34
2022 Q4 3,450,752 $11,559,435 +$1,794,750 $3.35 29
2022 Q3 2,944,976 $11,557,393 +$2,033,823 $3.92 30
2022 Q2 2,425,657 $7,008,000 -$295,144 $2.89 24
2022 Q1 2,519,448 $11,260,000 +$533,235 $4.47 26
2021 Q4 2,388,606 $9,291,000 -$320,941 $3.89 22
2021 Q3 2,435,140 $11,038,000 -$453,854 $4.50 20
2021 Q2 2,552,142 $10,232,010 -$7,325,561 $4.01 25
2021 Q1 3,741,109 $20,422,460 +$4,105,982 $5.46 30
2020 Q4 2,992,235 $14,898,972 +$5,809,529 $4.98 26
2020 Q3 1,824,581 $12,642,930 +$3,889,298 $6.92 23
2020 Q2 1,256,827 $9,114,250 +$5,392,116 $7.25 23
2020 Q1 513,994 $3,675,329 +$1,997,425 $7.15 19
2019 Q4 234,976 $705,024 +$14,000 $3.02 9
2019 Q3 232,774 $755,250 +$380,101 $3.24 10
2019 Q2 120,333 $313,600 -$18,502 $2.61 12
2019 Q1 126,398 $316,490 +$97,719 $2.50 11
2018 Q4 88,511 $151,700 -$189,611 $1.71 8
2018 Q3 160,931 $575,580 +$79,095 $3.57 7
2018 Q2 138,798 $538,890 +$119,682 $3.89 7
2018 Q1 107,763 $435,040 -$6,586 $4.02 6
2017 Q4 110,830 $416,740 +$180,260 $3.75 8
2017 Q3 66,682 $187,000 -$22,381 $2.81 6
2017 Q2 75,204 $199,000 -$14,850 $2.63 6
2017 Q1 80,821 $177,000 +$17,663 $2.20 6
2016 Q4 72,967 $165,000 +$113,375 $2.30 6
2016 Q3 23,332 $61,000 +$61,000 $2.62 3
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .